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Sinceitsinceptionalittleoverthreeyearsago,PPARResearch
has become a vibrant forum showcasing global eﬀort in
this ever-expanding ﬁeld of research. Over this short period,
more than 200 articles have appeared in the journal, both
in regular and special issues. It is hoped that these articles
have served as catalysts for new initiatives within the ﬁeld.
The following is a brief overview of the 12 special issues
published, extracted from their respective editorials.
1.PPAR andBone Metabolism
In this inaugural special issue of PPAR Research, a compre-
hensive overview of the role of PPAR-γ in the control of
bone maintenance is presented. Articles published cover (1)
PPAR-γ’s role in mesenchymal stem cell lineage allocation,
(2) possible cross-talk with relevant nuclear receptors, (3)
examination of PPAR-γ gene polymorphisms and bone
mineral density in humans, (4) a role of PPAR-γ in
bone loss due to skeletal disuse, (5) evidence that human
bone is vulnerable to antidiabetic therapies using PPAR-γ
agonists, the thiazolidinediones, and (6) evidence that the
antiosteoblastic activity of PPAR-γ can be separated from
its proadipocytic and antidiabetic activities. Also presented
in this special issue is a novel hypothesis stipulating that
PPAR-γ acts as a regulator of chondrocyte development and
cartilage homeostasis.
2.PPARs andObesity
This special issue begins with a review of key observations
in human subjects harboring genetic variations in PPARγ
and a thorough overview of the metabolic eﬀects of PPARs
in genetically modiﬁed animal models. The interaction of
PPARs with uncoupling proteins regulating energy expen-
diture is reviewed as are recent developments with RXR
agonists. A closely related topic addressed is the molecu-
lar and physiological functions of PPAR coactivators and
corepressors in relationship to adipocyte energy metabolism.
In addition, the potential advantages of selective PPAR
agonists are discussed. The intriguing possibility that PPARs
may mediate eﬀects of caloric restriction on longevity
is also considered. Finally, evidence that PPARs may be
interesting therapeutic targets to modulate obesity-induced
inﬂammation is reviewed.
3.PPARs inLungPathophysiology andDisease
This special issue contains a comprehensive group of reviews
and original investigations illustrating the pivotal role of
PPARs in the regulation of multiple cellular events in
lung pathogenesis. Such events include lung morphogenesis,
the inhibition of the release of inﬂammatory mediators
from lung immune and stromal/parenchymal cells in vitro,
and dampening both inﬂammation and damage in animal
models of acute lung injury (ALI), ischemia-reperfusion
injury, and allergic airways inﬂammation. Also covered
are lung tissue remodeling and the ﬁbroproliferation that
occur in chronic airways disease, ALI, pulmonary vascular
disease, and pulmonary ﬁbrosis. In addition, activation
of key macrophage antimicrobial and reparative responses
within the airspace is addressed, also data illuminating the
central role of PPAR-γ in the regulation of critical aspects
of lung tumor initiation, progression, and metastasis are
summarized.2 PPAR Research
4. PPARs, RXRs and Stem Cells
This special issue compiles a mixture of excellent primary
research manuscripts and comprehensive review articles
from experts in the ﬁeld covering the role of PPARs and
RXRs in (1) murine embryonic stem cell diﬀerentiation
and function, (2) hematopoietic stem cells, and (3) the
classical role of PPARγ as an adipogenic regulator in adipose
tissue-derived stromal/stem cells. In addition, investigations
examining bone marrow-derived mesenchymal stem cell
(MSC) models provided novel ﬁndings relating to (1) the
role of mystatin and GILZ on adipogenesis in response to
PPAR ligands, (2) the transcriptomic response of MSCs
to PPARγ agonists, and (3) the role for farnesylation in
modulating MSC adipogenesis are detailed. Finally, novel
insights into the eﬀect of PPARγ during neural stem cell
astroglial diﬀerentiation are presented.
5.PPARs/RXRs inCardiovascular
Physiology andDisease
This special issue contains a series of high-quality reviews
starting with an examination of the eﬀects of PPARs on
lipoprotein metabolism, followed by a review evaluating the
anti-inﬂammatory eﬀects of PPARs in platelets, an emerging
and important mechanism of the beneﬁcial eﬀects of these
receptors. Next, an excellent discussion of the critical role
that PPARα and its transcriptional coactivator protein PGC-
1α play in regulating energy metabolism and function of the
myocardium is presented. Then there is a series of reviews
focusing on the potentially beneﬁcial eﬀects of PPARγ ago-
nists on the cardiovascular system. Another review discusses
the potential input of the hexarelin signaling pathway in
regulatingPPARγ activityanditspotentialimpactoncardio-
metabolic disease. The pharmacogenomics of PPARs are also
discussed in another review. Finally, the potential toxicity
and adverse outcomes of PPAR agonism are summarized.
In addition to these reviews, this special issue contains
two original research reports. The ﬁrst report discusses
an association between PPARγ gene polymorphisms and
several cardio-metabolic indices, but found no link with
cardiovascular morbidity or mortality. The second study
details an important role forPGC-1α in post-natal metabolic
maturation.
6.PPARs andRXRs inMale andFemale
Fertilityand Reproduction
In this special issue, a broad picture of the potential role of
the PPAR-RXR system in the reproductive axis is presented,
raising new questions about the biological actions of this
system in reproduction and its possible manipulation in
treatments of fertility disorders. Presented reviews cover
metabolic and immune contributions of PPARs to female
fertility and reproduction to development of gametes and
the preimplantation of embryos and placental development
and function. Additional reviews discuss the roles of PPARs
in the fetal origin of metabolic diseases and as mediators
of phthalate-induced toxic eﬀects in male and female repro-
ductive tract. In conclusion, PPAR-γ as a potent target for
prevention and treatment of human prostate and testicular
cancer is reviewed.
7.PPARs inEye Biology andDisease
This special issue contains a comprehensive group of
reviews focused on the relationships of PPARs, choroidal
neovascularization, inﬂammation, redox balance, and the
perspectivetherapeuticpotentialsofPPARmodulatorsineye
diseases. Also, in this special issue, 3 papers are presented
reviewing the current knowledge of the relationship between
the PPAR isoforms, α, β,a n dδ, and ocular angiogenesis
with emphasis on age-related macular degeneration (AMD).
An authoritative fourth paper addresses PPARγ agonists as
potential therapies for non-AMD proliferative retinopathies.
Furthermore, presented are explorations of the roles of
PPARγ in microglial cell functions, therapeutic potentials
of PPARγ ligands on ocular diseases such as AMD, diabetic
retinopathy, autoimmune uveitis and optic neuritis, and the
roleofPPARγ inthebreakdownofblood-retinalbarrier.Also
included is an extensive review of the role of lymphocytes
in thyroid eye disease-related inﬂammation, which oﬀered
PPARγ ligands as a potential therapeutic approach to this
disorder. This special issue closes with a brief review of the
cytoprotective eﬀects of an endogenous PPARγ agonist, 15d-
PGJ2,onoxidativestress-inducedretinalpigmentepithelium
cell death.
8. PPARs in Neuroinﬂammation
This special issue contains a series of reviews concerning
the role of PPARs in neuroinﬂammatory diseases, as well as
the potential role of PPARs in modulating CNS disorders
including multiple sclerosis, Alzheimer’s disease, spinal cord
injury, stroke, traumatic brain injury, amyotrophic lateral
sclerosis, and Huntington’s disease. Also included in this
specialissuearereviewsconcerningtheroleofPPARagonists
in modulating the function of resident CNS microglia,
and the molecular mechanisms by which PPARs regulate
inﬂammatory signaling as related to CNS disease. This
special issue also contains two original research reports.
The ﬁrst report provides a thorough investigation of the
eﬀects of PPAR-γ agonists in modulating the production of
proinﬂammatorymoleculesbyCNSmicrogliaandastrocytes
in response to distinct toll-like receptor ligands relevant
to infections of the CNS. The second report investigates
PPAR-γ agonist eﬀects on amyloid beta-mediated microglial
productionofcytokinesknowntoalterT-celldiﬀerentiation.
9. PPARs: A Double-Edged Sword in
Cancer Therapy?
Thetitle ofthisspecialissuereﬂectstheunsolvedparadoxical
and mechanistically unclear eﬀects of PPARs in cancer
which can work both for and against this disease. This
special issue contains 56 contributions which illuminatePPAR Research 3
these disparate aspects of PPARs’ role in cancer. They are
organized in six diﬀerent sections. Section 1 is a valuable
collection of comprehensive overviews on PPARs in cancer
and on the more established role of PPARγ in cancer
therapy. This is followed by Sections 2, 3, 4 with articles that
discuss the following three key questions, respectively: (a)
are PPARs friends or foes of tumors?, this basic dichotomy
of PPARs’ role in cancer has been fostered by numerous
conﬂicting but unambiguous observations, (b) do PPARs
modulate tumor cell-autonomous or non-cell autonomous
(stromal) processes?, a question mirroring the emerging
picture of neoplasia as a tissue disorder in which stromal
cells play a critical role, and (c) are the cancer-related
eﬀects of PPAR ligands mediated by PPAR-dependent or
independent “oﬀ-target” mechanisms? This special issue is
closed with Section 5 which focuses on PPAR ligand-based
cancer therapies and Section 6 which covers the potential
molecular mechanisms of these ligands.
10.Development of SyntheticModulators
of PPARs: CurrentChallenges and Future
Opportunities
Reports highlighting both challenges and opportunities in
PPAR drug development are contained in this special issue.
Clinical studies describing the eﬀects of thiazolidinediones
(TZD) on lipids, lipoproteins, and apolipoproteins are
presented. Mechanism of TZDs in ﬂuid retention and
clinical data describing their eﬀects on bone are also
reviewed. In addition, the roles of PPARs in atherosclerosis
and metabolic disorders as well as various strategies and
technologies used in the identiﬁcation and assessment of
PPAR agonists are presented. Furthermore, eﬀects of PPAR-
α and PPAR-γ ligands on cysteinyl leukotriene production
in mast cells as it relates to the development of potential
anti-asthma medications are covered in this special issue.
Species diﬀerences in plasma protein binding and in PPARγ
activation by a novel agonist, MBX-102, are described.
Finally, the synthesis and SAR of subtype-speciﬁc PPAR
agonists derived from a single 3,4-disubstituted phenyl-
propanoic acid “versatile template” scaﬀold is reported,
along with a description of the development and safety
proﬁle of INT-131, a potent non-TZD selective PPAR
modulator (SPPARM), a compound currently in Phase 2
clinical development.
11. PeroxisomeProliferator-Activated
Receptor δ:AT arg etwit haB r oad
Therapeutic Potential for Drug Discovery
The broad potential of PPAR-δ agonists for the treatment
of metabolic disease is brought to light in this special
issue. This includes a review on the regulation of the
oxidative capacity of muscle by PPAR-δ, opportunities for
the development of PPAR-δ agonists for the treatment
of obesity, and ﬁnally the eﬀect of PPAR-δ activation on
vascular pathophysiological processes. The eﬀects of PPAR-
δ activation on cell proliferation and the risk of inducing
cancer, an area of conﬂicting results and intense debate, is
concisely reviewed in this special issue. Last but certainly
not least, two additional interesting facets of PPAR-δ biology
are presented. First, as PPAR-δ is expressed at high level
in the brain, the potential neuroprotective role of PPAR-
δ activation was detailed. Second, although the role of
PPAR-δ in embryo implantation was recognized early on,
the reproductive functions of PPAR-δ are still unclear. The
latter issue is addressed in a review addressing potential
applications of PPAR-δ ligands in assisted reproductive
technology.
12.PPARs inViralDisease
This special issue contains an exciting array of valuable
reviews examining the relationship between PPARs and
various viral infections. First, the cross-talk between HIV
infection and PPARγ leading to the reported negative
impact of this interplay on adipose tissue physiology is
presented. Second, the eﬀect of ART on adipocyte PPARγ
expression in vitro, in animal models, and in HIV-infected
patients is summarized. In the third review, the results of
14 diﬀerent clinical trials which evaluated if the PPARγ
thiazolidinedioneagonistscouldbeusefulinthetreatmentof
HAART-associated metabolic complications in HIV-infected
patients are closely examined. In addition, there is a review
which focuses on the potential role of PPARγ in HIV-
1-associated bone disease culminating with a provocative
hypothesis stipulating a potential role for PPARγ in the
reduced bone mass associated with HIV-1 infection and
treatment. As the liver is not only impacted by HIV but also
by HBV and HCV, this organ is the focus of several excellent
reviews in this special issue. First, the role that PPARs
play in HIV infection, in terms of associated metabolic
disorders, disease progression, coinfections with HBV or
HCV and response to antiviral treatment is featured in a
review. Further, experimental and clinical data suggesting
that HCV may interfere with hepatic insulin signaling,
possibly involving the downregulation of the PPARγ are
presented. Another review has summarized experimental
and human studies showing a diminished expression and
function of PPARα and PPARγ during HCV infection. An
additional review discusses the potential of PPARs to mod-
ulate HBV transcription and replication, concluding with
the proposal that modulating the PPARα/RXR heterodimer
may be an interesting therapeutic option to control HBV
infection.
Examining the contents of these special issues reveals
an intense interest in exploring new physiological roles of
the PPARs and in the identiﬁcation of new and improved
PPAR agonist drugs. Nonetheless, safety issues raised for the
currently marketed PPAR drugs should not be overlooked,
andmustbeaddressed.TheEditorialTeamofPPARResearch
iscommittedtomakingthejournalapremierevehicleforthe
publicationofthelatestdiscoveriesintheseandotheraspects
of the ﬁeld.
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